McKenna Mark C.

McKenna Mark C. is listed in public filings as director. This McKenna Mark C. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE), NewAmsterdam Pharma Company N.V. (NAMS), BridgeBio Oncology Therapeutics Inc. (BBOT), and Apogee Therapeutics, Inc. (APGE). Investors use McKenna Mark C.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.